Offer - Urjas Oil for just ₹ 1 X
Wosulin 50/50 Injection 40 IU/ Ml is a prescription medicine that is available as a Injection. It is typically used for the treatment of Diabetes Type 1, Diabetes Type 1. Other than this, Wosulin 50/50 Injection 40 IU/ Ml has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Wosulin 50/50 Injection 40 IU/ Ml. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Wosulin 50/50 Injection 40 IU/ Ml side effects, there are can be others also. These have been listed below. Normally, these side effects of Wosulin 50/50 Injection 40 IU/ Ml are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Wosulin 50/50 Injection 40 IU/ Ml is Safe for pregnant women and Unknown for women who are breastfeeding. In addition, Wosulin 50/50 Injection 40 IU/ Ml's effects on the liver, heart and kidney are discussed below in the Wosulin 50/50 Injection 40 IU/ Ml related warnings section.
Some other conditions that can be affected by Wosulin 50/50 Injection 40 IU/ Ml are listed in the contraindications section below.
Additionally, Wosulin 50/50 Injection 40 IU/ Ml may also adversely react with other medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Wosulin 50/50 Injection 40 IU/ Ml is considered safe while driving, and is addictive.
Wosulin 50/50 Injection 40 IU/ Ml is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Wosulin 50/50 Injection 40 IU/ Ml safe for pregnant women?
Wosulin is safe for pregnant women.
Is the use of Wosulin 50/50 Injection 40 IU/ Ml safe during breastfeeding?
Information about safety of Wosulin for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Wosulin 50/50 Injection 40 IU/ Ml on the Kidneys?
Wosulin may have mild side effects on the kidneys.
What is the effect of Wosulin 50/50 Injection 40 IU/ Ml on the Liver?
Very few cases of side effects of Wosulin on the liver have been reported.
What is the effect of Wosulin 50/50 Injection 40 IU/ Ml on the Heart?
Very few cases of side effects of Wosulin on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Wosulin 50/50 Injection 40 IU/ Ml unless your doctor advises you to do so -
Is this Wosulin 50/50 Injection 40 IU/ Ml habit forming or addictive?
No, you will not get addicted to Wosulin 50/50 Injection 40 IU/ Ml.
Interaction between Food and Wosulin 50/50 Injection 40 IU/ Ml
There is no information on the effects of taking Wosulin 50/50 Injection 40 IU/ Ml with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Wosulin 50/50 Injection 40 IU/ Ml
Drinking alcohol while taking Wosulin 50/50 Injection 40 IU/ Ml may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Novolin® N (Human Insulin Isophane)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Humulin® N (Human Insulin Isophane)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 693-695
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Humulin® R (regular insulin human)